bioRxivPharmacology & Toxicology
The ENDS of assumptions; an online tool for the Epistemic Nonparametric Drug-response Scoring
Abstract
MotivationThe drugs sensitivity analysis is often elucidated from drug dose-response curves. These curves capture the degree of cell viability (or inhibition) over a range of induced drugs, often with parametric assumptions that are rarely validated. ResultsWe present a class of nonparametric models for the curve fitting and scoring of drug dose-responses. To allow a more objective representation of the drug sensitivity, these epistemic models devoid of any parametric assumptions attached to the linear fit, allow the parallel indexing such as IC50 and AUC. Specifically, three nonparametric models including Spline, Monotonic, and Bayesian (npS, npM, npB) and the parametric Logistic (pL) are implemented. Other indices including Maximum Effective Dose (MED) and Drug-response Span Gradient (DSG) pertinent to the npS are also provided to facilitate the interpretation of the fit. The collection of these models are implemented in an online app, standing as useful resource for drug dose-response curve fitting and analysis. AvailabilityThe ENDS is freely available online at https://irscope.shinyapps.io/ENDS/ and source codes can be obtained from https://github.com/AmiryousefiLab/ENDS. Supplementary informationSupplementary data are available at Bioinformatics and https://irscope.shinyapps.io/ENDS/ Contactali.amiryousefi@helisnki.fi; jing.tang@helisnki.fi. ContributionsAA conceived the study and developed the models, AA and BW adopted and implemented the methods, JT provided the funding, AA, BW, MJ, and JT wrote the paper.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- drda: An R package for dose-response data analysis
Alina Malyutina, Jing Ping Tang, Alberto Pessia·bioRxiv·Jun 7, 2021
- CurveCurator: A recalibrated F-statistic to assess, classify, and explore significance of dose-response curves
Florian P Bayer, Manuel Gander, … Matthew The·Nature CommunicationsPeer-reviewed·Nov 30, 2023
- A sigmoid curve analysis method for pharmacological experimental results
- Robust and Efficient Assessment of Potency (REAP): A Quantitative Tool for Dose-response Curve Estimation
- A reference model for the combination of an arbitrary number of drugs: A generalization of the Bliss independence model
W. De Mulder, M. Kuiper, A. Flobak·bioRxiv·May 7, 2019
- A normalized drug response metric improves accuracy and consistency of drug sensitivity quantification in cell-based screening
Abhishekh Gupta, Prson Gautam, … Tero A. Aittokallio·Communications BiologyPeer-reviewed·Jan 23, 2020